| No images? Click here Monday 13 April, 2020  Dear Journalists, Please find below two items of interest from WHO related to COVID-19: Public statement for collaboration on COVID-19 vaccine development 13 April 2020/Statement On 31 December 2019, the World Health Organization (WHO) was informed of a cluster of cases of pneumonia of unknown cause detected in Wuhan City, Hubei Province of China. Chinese authorities identified the SARS-CoV-2 as the causative virus on 7 January 2020, and the disease was named coronavirus disease 2019 (COVID-19) by WHO on 11 February 2020. As part of WHO’s response to the outbreak, a Research and Development (R&D) Blueprint has been activated to accelerate the development of diagnostics, vaccines and therapeutics for this novel coronavirus. Under WHO’s coordination, a group of experts with diverse backgrounds is working towards the development of vaccines against COVID-19. The group makes a call to everyone to follow recommendations to prevent the transmission of the COVID-19 virus and protect the health of individuals. The group also thanks everyone for putting their trust in the scientific community. Please click the above link for the full Declaration and signatories. OTHER NEWS: Please find the link to the scientific brief on Bacille Calmette-Guérin vaccine (BCG) and COVID-19: PLEASE NOTE: We will be making changes to better validate our emails and their content so that your anti-spam software can make better decisions about the legitimacy of our news products. From 14 April, 2020, email messages you receive from WHO will come from @campaign.who.int instead of @who.int. Best regards, WHO Media Team You are receiving this email because you are included on a WHO mail list. |
Your Highlights
Comments
Post a Comment